Abstract
Loss of Abcc6 gene expression was identified to be responsible for dystrophic calcification of the heart (DCC) or vessels after acute injury in several strains of laboratory mice. This calcification shares features with osteogenesis and may involve osteogenic factors. Tissue expression of osteopontin (Opn) and 11 osteogenic transcription factors were studied in vivo in mouse models for DCC and in vitro using luciferase reporter gene assays. Compared with DCC-resistant C57BL/6 mice, a significant increase in Opn transcription was demonstrated in necrotic lesions of both DCC-susceptible C3H/He and B6.C3HDyscalc1 congenic mice at day 3 after injury. Significant increases in gene expression were also demonstrated for the transcription factors runt domain-containing transcription factor 2 (Runx2), vitamin D receptor (Vdr), SRY (sex-determining region Y)-box 9 protein, and Nfkb1 in C3H/He mice versus C57BL/6 controls. However, only Runx2 remained significantly increased in the B6.C3HDyscalc1 congenic mice, which carry only the Dyscalc1 locus with functional Abcc6 deletion on a C57BL/6 genetic background. Luciferase assay use increased Opn promoter activity, which was demonstrated after overexpression of Runx2. A poly-T stretch insertion was identified to stabilize the binding of Runx2, thus significantly enhancing Opn promoter activity. This Runx2-mediated activation was further enhanced by cotransfection with Vdr. Our data suggest a key role of Runx2 in the regulation of Opn in a model of cardiovascular calcification and demonstrate a synergistic cooperation of Runx2 and Vdr.
| Original language | English |
|---|---|
| Journal | American Journal of Pathology |
| Volume | 183 |
| Issue number | 1 |
| Pages (from-to) | 60-68 |
| Number of pages | 9 |
| ISSN | 0002-9440 |
| DOIs | |
| Publication status | Published - 01.07.2013 |
Funding
We thank Janine Stegmann, Maren Behrensen, and Annett Liebers for expert technical assistance; Dr. Jennifer Freyer, Philip Moritz Rumpf, Friederike Schürmann, and Jaafar Al-Hasani for help and advice; Dr. Manuela Wülling (Centre for Medical Biotechnology, Essen, Germany) for providing the Runx2-expression plasmid; Renate Domeier for reading the manuscript; and Dr. Ralf Noel and Jessica Redmer for advice and support in matters of animal maintenance.